Vasänge M - Search Results

1

The flavonoid constituents of two Polypodium species (Calaguala) and their effect on the elastase release in human neutrophils.

Vasänge M, Liu B, Welch CJ, Rolfsen W, Bohlin L. Vasänge M, et al. Planta Med. 1997 Dec;63(6):511-7. doi: 10.1055/s-2006-957753. Planta Med. 1997. PMID: 9434602

2

Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.

Huss U, Ringbom T, Perera P, Bohlin L, Vasänge M. Huss U, et al. Among authors: vasange m. J Nat Prod. 2002 Nov;65(11):1517-21. doi: 10.1021/np020023m. J Nat Prod. 2002. PMID: 12444669

3

A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils.

Vasänge M, Rolfsen W, Bohlin L. Vasänge M, et al. J Pharm Pharmacol. 1997 May;49(5):562-6. doi: 10.1111/j.2042-7158.1997.tb06842.x. J Pharm Pharmacol. 1997. PMID: 9178195

4

Quantitative determination of antiinflammatory principles in some Polypodium species as a basis for standardization.

Liu B, Diaz F, Bohlin L, Vasänge M. Liu B, et al. Among authors: vasange m. Phytomedicine. 1998 May;5(3):187-94. doi: 10.1016/S0944-7113(98)80026-3. Phytomedicine. 1998. PMID: 23195839

5

Characterization of a new muscarinic receptor antagonist PNU-171990 in guinea pig, cat and human smooth muscle.

Modiri AR, Vasänge M, Alberts P, Jossan SS, Sundquist S, Gillberg PG. Modiri AR, et al. Among authors: vasange m. Eur J Pharmacol. 2002 Sep 13;451(2):171-5. doi: 10.1016/s0014-2999(02)02227-6. Eur J Pharmacol. 2002. PMID: 12231388

6

Assay suitability for natural product screening: searching for leads to fight Alzheimer's disease.

Vasänge M. Vasänge M. Planta Med. 2014 Sep;80(14):1200-9. doi: 10.1055/s-0034-1383063. Epub 2014 Sep 15. Planta Med. 2014. PMID: 25221979 Review.

7

Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors.

Malmström J, Viklund J, Slivo C, Costa A, Maudet M, Sandelin C, Hiller G, Olsson LL, Aagaard A, Geschwindner S, Xue Y, Vasänge M. Malmström J, et al. Among authors: vasange m. Bioorg Med Chem Lett. 2012 Sep 15;22(18):5919-23. doi: 10.1016/j.bmcl.2012.07.068. Epub 2012 Jul 25. Bioorg Med Chem Lett. 2012. PMID: 22889803

8

Identification of non-muscle myosin heavy chain as a substrate for Cdk5 and tool for drug screening.

Jämsä A, Agerman K, Radesäter AC, Ottervald J, Malmström J, Hiller G, Liu G, Vasänge M. Jämsä A, et al. Among authors: vasange m. J Biomed Sci. 2009 Jun 17;16(1):55. doi: 10.1186/1423-0127-16-55. J Biomed Sci. 2009. PMID: 19534817 Free PMC article.

9

Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.

Jämsä A, Bäckström A, Gustafsson E, Dehvari N, Hiller G, Cowburn RF, Vasänge M. Jämsä A, et al. Among authors: vasange m. Biochem Biophys Res Commun. 2006 Jun 23;345(1):324-31. doi: 10.1016/j.bbrc.2006.04.032. Epub 2006 May 6. Biochem Biophys Res Commun. 2006. PMID: 16678793

10

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.

Jämsä A, Hasslund K, Cowburn RF, Bäckström A, Vasänge M. Jämsä A, et al. Among authors: vasange m. Biochem Biophys Res Commun. 2004 Jul 2;319(3):993-1000. doi: 10.1016/j.bbrc.2004.05.075. Biochem Biophys Res Commun. 2004. PMID: 15184080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results